UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000036275 |
|---|---|
| Receipt number | R000041316 |
| Scientific Title | Protective and ameliorative effects of the extracts of Cistanche tubulosa on locomotive syndrome. |
| Date of disclosure of the study information | 2019/04/01 |
| Last modified on | 2020/03/12 10:41:30 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Protective and ameliorative effects of the extracts of Cistanche tubulosa on locomotive syndrome.
Acronym
Protective and ameliorative effects of the extracts of Cistanche tubulosa on locomotive syndrome.
Scientific Title
Protective and ameliorative effects of the extracts of Cistanche tubulosa on locomotive syndrome.
Scientific Title:Acronym
Protective and ameliorative effects of the extracts of Cistanche tubulosa on locomotive syndrome.
Region
| Japan |
Condition
Condition
Subjects having the risk of locomotive syndrome
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
This study aims to investigate effects of the extract of Cistanche tubulosa on locomotive syndrome.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Function of locomotive systems
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
NO
Dynamic allocation
NO
Institution consideration
Institution is not considered as adjustment factor.
Blocking
NO
Concealment
Numbered container method
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Food |
Interventions/Control_1
Tretament test drug: Intake of powder containing the extracts of Cistanche tubulosa (1800 mg/bag), one bag per day, for 12 weeks.
Interventions/Control_2
Treatment placebo:Intake of powder without the extract, one bag per day, for 12 weeks.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 40 | years-old | <= |
Age-upper limit
| 80 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Subjects who checked at least one item among "Loco check" between age 40 to 80 years old, who volunteers to attend this clinical study.
Key exclusion criteria
Subjects under 20 years old, pregnant or lactating. Subjects during medication such as muscle relaxants, osteoporosis drugs, rheumatoid arthritis drugs.
Subjects having mental illnesses. Subjects judged being inappropriate by other reasons.
Target sample size
20
Research contact person
Name of lead principal investigator
| 1st name | Chihiro |
| Middle name | |
| Last name | Tohda |
Organization
University of Toyama
Division name
Division of Neuromedical Science, Institute of Natural Medicine
Zip code
930-0194
Address
2630 Sugitani, Toyama, 930-0194, JAPAN
TEL
076-434-7646
chihiro@inm.u-toyama.ac.jp
Public contact
Name of contact person
| 1st name | Chihiro |
| Middle name | |
| Last name | Tohda |
Organization
University of Toyama
Division name
Division of Neuromedical Science, Institute of Natural Medicine
Zip code
930-0194
Address
2630 Sugitani, Toyama, 930-0194, JAPAN
TEL
076-434-7646
Homepage URL
chihiro@inm.u-toyama.ac.jp
Sponsor or person
Institute
Division of Neuromedical Science, Institute of Natural Medicine, University of Toyama
Institute
Department
Personal name
Funding Source
Organization
MEXT
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
IRB center, Sugitani campus, University of Toyama
Address
2630 Sugitani, Toyama, 930-0194, JAPAN
Tel
076-434-7145
yuka@adm.u-toyama.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
国立大学法人 富山大学
Other administrative information
Date of disclosure of the study information
| 2019 | Year | 04 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
20
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2018 | Year | 11 | Month | 02 | Day |
Date of IRB
| 2018 | Year | 11 | Month | 26 | Day |
Anticipated trial start date
| 2019 | Year | 05 | Month | 11 | Day |
Last follow-up date
| 2019 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2019 | Year | 03 | Month | 22 | Day |
Last modified on
| 2020 | Year | 03 | Month | 12 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041316
